pid-221203161255-84df03af.pdf

PELVIC INFLAMMATORY
DISEASE
Dr. Yashika
Definition
 PID is a disease of the upper genital tract.
 It is a spectrum of infection and
inflammation of the upper genital tract
organs typically involving the uterus
(endometrium), fallopian tubes, ovaries,
pelvic peritoneum and surrounding
structures.
Epidemiology
 Occurs both in the developed and developing
countries.
 85 per cent are spontaneous infection in
sexually active females of reproductive age.
 The remaining 15 per cent follow procedures,
which favors the organisms to ascend up.
 Two-thirds are restricted to young women of
less than 25 years and the remaining one-third
limited among 30 years or older.
Risk factors
 Menstruating teenagers.
 Multiple sexual partners.
 Absence of contraceptive pill use.
 Previous history of acute PID.
 IUD users.
 Area with high prevalence of sexually
transmitted diseases.
Protective factors
 „
Contraceptive practice
Barrier methods
Oral steroidal contraceptives
Monogamy / Vasectomy
 „
Others
Pregnancy
Menopause
Vaccines
CLINICAL FEATURES
 Bilateral lower abdominal and pelvic pain dull
in nature.
 Fever, lassitude and headache.
 •
•
Irregular and excessive vaginal bleeding .
 Abnormal vaginal discharge (purulent or
copious)
 •
•
Nausea and vomiting.
 •
•
Dyspareunia.
 •
•
Pain and discomfort in the right
hypochondrium.
Signs
 Temperature >38.3°C.
 •
•
Abdominal palpation
(1) Tenderness on both the quadrants of lower abdomen.
(2) The liver may be enlarged and tender.
 •
•
Vaginal examination
(1) Abnormal vaginal discharge (purulent).
(2) Congested external urethral meatus or openings of Bartholin’s ducts
through which pus may be seen escaping out on pressure.
(3) Speculum examination shows congested cervix with purulent discharge
from the canal.
Clinical diagnostic criteria of PID
(CDC-2006)
 Minimum Criteria
Lower abdominal tenderness.
Adnexal tenderness.
Cervical motion tenderness.
 •
•
Additional Criteria
Oral temperature > 38.3°C.
Mucopurulent cervical or vaginal discharge.
Raised C-reactive protein and/or ESR.
 Definitive Criteria
Histopathologic evidence of endometritis on biopsy.
Imaging study (TVS/MRI) evidence of tubo-ovarian complex.
Laparoscopic evidence of PID
Investigations
 Identification of organisms
 Blood: Leucocyte count shows
leucocytosis to more than 10,000 per cu mm
and an elevated ESR value of more than 15
mm per hour.
 Laparoscopy
Complications Of Pid
Immediate
1) Pelvic peritonitis or even generalized
2) Septicemia
Late
(1) Dyspareunia
(2) Infertility
(3) Chronic pelvic inflammation
(4) Formation of adhesions or hydrosalpinx or pyosalpinx and tubo-
ovarian abscess.
(5) Chronic pelvic pain and ill health.
Ambulatory Management Of Acute PID
(CDC-2006)
Patient should have oral therapy for 14 days
 „Regimen A
Levofloxacin 500 mg (or, ofloxacin 400 mg)
PO
Metronidazole 500 PO bid
 „Regimen B
Ceftriaxone 250 mg IM single dose
Doxycycline 100 mg PO BID with or without
Metronidazole 500 mg PO BID for 14 days
Inpatient Antibiotic Therapy
(CDC–2006)
Regimen A
Cefoxitin 2 gm iv every 6 hours for 2-4 days
„Doxycycline 100 mg Po for 14 days
Regimen B
„Clindamycin 900 mg iv every 8 hours
„Gentamicin 2 mg/kg iv
Alterntive regimen
„
Levofloxacin 500 mg iv
Metronidazole 500 mg iv
Thank you
1 de 13

Recomendados

Pelvic inflammatory disease (PID) por
Pelvic inflammatory disease (PID)Pelvic inflammatory disease (PID)
Pelvic inflammatory disease (PID)Ali Kareem
225 vistas18 diapositivas
Pelvic Inflammatory Disease por
Pelvic Inflammatory DiseasePelvic Inflammatory Disease
Pelvic Inflammatory DiseaseFreeMedicine
85 vistas34 diapositivas
Pelvic inflammatory disease por
Pelvic inflammatory diseasePelvic inflammatory disease
Pelvic inflammatory diseasedrmcbansal
74.7K vistas58 diapositivas
Pid 2019 por
Pid 2019Pid 2019
Pid 2019magajadickson
68 vistas33 diapositivas
Pid by dr naz pptx por
Pid  by dr naz pptxPid  by dr naz pptx
Pid by dr naz pptxdr shabnam naz shaikh
404 vistas38 diapositivas
Pelvic inflammatory disease (pid) por
Pelvic inflammatory disease (pid)Pelvic inflammatory disease (pid)
Pelvic inflammatory disease (pid)Jograjiya Gelabhai Raghubhai
34.4K vistas59 diapositivas

Más contenido relacionado

Similar a pid-221203161255-84df03af.pdf

Presentation1 por
Presentation1Presentation1
Presentation1imral12345
606 vistas35 diapositivas
CERVICAL CANCER.ppt por
CERVICAL CANCER.pptCERVICAL CANCER.ppt
CERVICAL CANCER.pptFeniksRetails
501 vistas46 diapositivas
PID lecture by Associate Professor Dr Aisha Elbareg por
PID lecture by Associate Professor Dr Aisha ElbaregPID lecture by Associate Professor Dr Aisha Elbareg
PID lecture by Associate Professor Dr Aisha ElbaregDr. Aisha M Elbareg
4.5K vistas70 diapositivas
Puperial sepsis por
Puperial sepsisPuperial sepsis
Puperial sepsisishamagar
786 vistas66 diapositivas
Genital tuberculosis por
Genital tuberculosisGenital tuberculosis
Genital tuberculosisJaya Kore Tulaskar
45.1K vistas86 diapositivas
Preterm por
PretermPreterm
PretermDrpawan Jhalta
20.8K vistas108 diapositivas

Similar a pid-221203161255-84df03af.pdf(20)

Presentation1 por imral12345
Presentation1Presentation1
Presentation1
imral12345606 vistas
PID lecture by Associate Professor Dr Aisha Elbareg por Dr. Aisha M Elbareg
PID lecture by Associate Professor Dr Aisha ElbaregPID lecture by Associate Professor Dr Aisha Elbareg
PID lecture by Associate Professor Dr Aisha Elbareg
Dr. Aisha M Elbareg4.5K vistas
Puperial sepsis por ishamagar
Puperial sepsisPuperial sepsis
Puperial sepsis
ishamagar786 vistas
Pid por ketkii T
PidPid
Pid
ketkii T370 vistas
GYNAE bleeding in a early pregnancy.docx por christinetoywa
GYNAE  bleeding in a early pregnancy.docxGYNAE  bleeding in a early pregnancy.docx
GYNAE bleeding in a early pregnancy.docx
christinetoywa15 vistas
Gynaecological emergencies por drbarai
Gynaecological emergenciesGynaecological emergencies
Gynaecological emergencies
drbarai10.2K vistas
Pelvic inflammatory disease por mediwaves
Pelvic inflammatory diseasePelvic inflammatory disease
Pelvic inflammatory disease
mediwaves7.4K vistas
G Y N E C O L O G I C N U R S I N G por diane_dona
G Y N E C O L O G I C  N U R S I N GG Y N E C O L O G I C  N U R S I N G
G Y N E C O L O G I C N U R S I N G
diane_dona3K vistas
(PID) PELVIC INFLAMMATORY DISEASE.pdf por Katongo Sandwe
(PID) PELVIC INFLAMMATORY DISEASE.pdf(PID) PELVIC INFLAMMATORY DISEASE.pdf
(PID) PELVIC INFLAMMATORY DISEASE.pdf
Katongo Sandwe136 vistas
Pelvic inflammatory disease por raj kumar
Pelvic inflammatory diseasePelvic inflammatory disease
Pelvic inflammatory disease
raj kumar9.6K vistas
PelvicInflammatoryDisease_Abbott.ppt por DINHMONGKAT
PelvicInflammatoryDisease_Abbott.pptPelvicInflammatoryDisease_Abbott.ppt
PelvicInflammatoryDisease_Abbott.ppt
DINHMONGKAT97 vistas

Más de KoangWichyoah

Anemia(8).pptx por
Anemia(8).pptxAnemia(8).pptx
Anemia(8).pptxKoangWichyoah
3 vistas12 diapositivas
Introduction of psychiarty.pptx por
Introduction of psychiarty.pptxIntroduction of psychiarty.pptx
Introduction of psychiarty.pptxKoangWichyoah
2 vistas46 diapositivas
iud-181125051025.pdf por
iud-181125051025.pdfiud-181125051025.pdf
iud-181125051025.pdfKoangWichyoah
22 vistas20 diapositivas
Lect_Diuretics(2).pdf por
Lect_Diuretics(2).pdfLect_Diuretics(2).pdf
Lect_Diuretics(2).pdfKoangWichyoah
7 vistas24 diapositivas
CVS(2).pdf por
CVS(2).pdfCVS(2).pdf
CVS(2).pdfKoangWichyoah
4 vistas37 diapositivas
PD.pdf por
PD.pdfPD.pdf
PD.pdfKoangWichyoah
61 vistas35 diapositivas

Último

status epilepticus-management por
status epilepticus-managementstatus epilepticus-management
status epilepticus-managementVamsi Krishna Koneru
11 vistas91 diapositivas
Structural Racism and Public Health: How to Talk to Policymakers and Communit... por
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...katiequigley33
849 vistas31 diapositivas
The Art of naming drugs.pptx por
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptxDanaKarem1
10 vistas48 diapositivas
Basic Life support (BLS) workshop presentation. por
Basic Life support (BLS) workshop presentation.Basic Life support (BLS) workshop presentation.
Basic Life support (BLS) workshop presentation.Dr Sanket Nandekar
36 vistas39 diapositivas
Top 10 Pharma Companies in Mumbai | Medibyte por
Top 10 Pharma Companies in Mumbai | MedibyteTop 10 Pharma Companies in Mumbai | Medibyte
Top 10 Pharma Companies in Mumbai | MedibyteMedibyte Pharma
21 vistas1 diapositiva
CRANIAL NERVE EXAMINATION.pptx por
CRANIAL NERVE EXAMINATION.pptxCRANIAL NERVE EXAMINATION.pptx
CRANIAL NERVE EXAMINATION.pptxNerusu sai priyanka
175 vistas30 diapositivas

Último(20)

Structural Racism and Public Health: How to Talk to Policymakers and Communit... por katiequigley33
Structural Racism and Public Health: How to Talk to Policymakers and Communit...Structural Racism and Public Health: How to Talk to Policymakers and Communit...
Structural Racism and Public Health: How to Talk to Policymakers and Communit...
katiequigley33849 vistas
The Art of naming drugs.pptx por DanaKarem1
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptx
DanaKarem110 vistas
Basic Life support (BLS) workshop presentation. por Dr Sanket Nandekar
Basic Life support (BLS) workshop presentation.Basic Life support (BLS) workshop presentation.
Basic Life support (BLS) workshop presentation.
Dr Sanket Nandekar36 vistas
Top 10 Pharma Companies in Mumbai | Medibyte por Medibyte Pharma
Top 10 Pharma Companies in Mumbai | MedibyteTop 10 Pharma Companies in Mumbai | Medibyte
Top 10 Pharma Companies in Mumbai | Medibyte
Medibyte Pharma21 vistas
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (... por PeerVoice
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (...
PeerVoice10 vistas
PCD Pharma Franchise In Chandigarh | Saphnix Lifesciences por Saphnix Lifesciences
PCD Pharma Franchise In Chandigarh | Saphnix LifesciencesPCD Pharma Franchise In Chandigarh | Saphnix Lifesciences
PCD Pharma Franchise In Chandigarh | Saphnix Lifesciences
Explore new Frontiers in Medicine with AI.pdf por Anne Marie
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
Anne Marie8 vistas
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences por Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix LifesciencesPharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Pharma Franchise For Critical Care Medicine | Saphnix Lifesciences
Cholera Romy W. (3).pptx por rweth613
Cholera Romy W. (3).pptxCholera Romy W. (3).pptx
Cholera Romy W. (3).pptx
rweth61349 vistas
Referral-system_April-2023.pdf por manali9054
Referral-system_April-2023.pdfReferral-system_April-2023.pdf
Referral-system_April-2023.pdf
manali905438 vistas
Pulmonary Embolism for Nurses.pptx por Asraf Hussain
Pulmonary Embolism for Nurses.pptxPulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptx
Asraf Hussain25 vistas
sales forecasting (Pharma) por sristi51
sales forecasting (Pharma)sales forecasting (Pharma)
sales forecasting (Pharma)
sristi518 vistas
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx por InkhaRina
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docxBUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
BUKTI SOSIALISASI KODE ETIK DAN PERATURAN INTERNAL.docx 4,2,C.docx
InkhaRina35 vistas

pid-221203161255-84df03af.pdf

  • 2. Definition  PID is a disease of the upper genital tract.  It is a spectrum of infection and inflammation of the upper genital tract organs typically involving the uterus (endometrium), fallopian tubes, ovaries, pelvic peritoneum and surrounding structures.
  • 3. Epidemiology  Occurs both in the developed and developing countries.  85 per cent are spontaneous infection in sexually active females of reproductive age.  The remaining 15 per cent follow procedures, which favors the organisms to ascend up.  Two-thirds are restricted to young women of less than 25 years and the remaining one-third limited among 30 years or older.
  • 4. Risk factors  Menstruating teenagers.  Multiple sexual partners.  Absence of contraceptive pill use.  Previous history of acute PID.  IUD users.  Area with high prevalence of sexually transmitted diseases.
  • 5. Protective factors  „ Contraceptive practice Barrier methods Oral steroidal contraceptives Monogamy / Vasectomy  „ Others Pregnancy Menopause Vaccines
  • 6. CLINICAL FEATURES  Bilateral lower abdominal and pelvic pain dull in nature.  Fever, lassitude and headache.  • • Irregular and excessive vaginal bleeding .  Abnormal vaginal discharge (purulent or copious)  • • Nausea and vomiting.  • • Dyspareunia.  • • Pain and discomfort in the right hypochondrium.
  • 7. Signs  Temperature >38.3°C.  • • Abdominal palpation (1) Tenderness on both the quadrants of lower abdomen. (2) The liver may be enlarged and tender.  • • Vaginal examination (1) Abnormal vaginal discharge (purulent). (2) Congested external urethral meatus or openings of Bartholin’s ducts through which pus may be seen escaping out on pressure. (3) Speculum examination shows congested cervix with purulent discharge from the canal.
  • 8. Clinical diagnostic criteria of PID (CDC-2006)  Minimum Criteria Lower abdominal tenderness. Adnexal tenderness. Cervical motion tenderness.  • • Additional Criteria Oral temperature > 38.3°C. Mucopurulent cervical or vaginal discharge. Raised C-reactive protein and/or ESR.  Definitive Criteria Histopathologic evidence of endometritis on biopsy. Imaging study (TVS/MRI) evidence of tubo-ovarian complex. Laparoscopic evidence of PID
  • 9. Investigations  Identification of organisms  Blood: Leucocyte count shows leucocytosis to more than 10,000 per cu mm and an elevated ESR value of more than 15 mm per hour.  Laparoscopy
  • 10. Complications Of Pid Immediate 1) Pelvic peritonitis or even generalized 2) Septicemia Late (1) Dyspareunia (2) Infertility (3) Chronic pelvic inflammation (4) Formation of adhesions or hydrosalpinx or pyosalpinx and tubo- ovarian abscess. (5) Chronic pelvic pain and ill health.
  • 11. Ambulatory Management Of Acute PID (CDC-2006) Patient should have oral therapy for 14 days  „Regimen A Levofloxacin 500 mg (or, ofloxacin 400 mg) PO Metronidazole 500 PO bid  „Regimen B Ceftriaxone 250 mg IM single dose Doxycycline 100 mg PO BID with or without Metronidazole 500 mg PO BID for 14 days
  • 12. Inpatient Antibiotic Therapy (CDC–2006) Regimen A Cefoxitin 2 gm iv every 6 hours for 2-4 days „Doxycycline 100 mg Po for 14 days Regimen B „Clindamycin 900 mg iv every 8 hours „Gentamicin 2 mg/kg iv Alterntive regimen „ Levofloxacin 500 mg iv Metronidazole 500 mg iv